Антиагрегантная терапия у больных ишемической болезнью сердца после хирургической реваскуляризации миокарда
https://doi.org/10.18705/1607-419X-2009-15-3-256-261
Аннотация
В статье представлены современные литературные данные о тактике антиагрегантной терапии у больных ишемической болезнью сердца (ИБС), которым планируется выполнение операции аорто-коронарного шунтирования. Приводятся результаты рандомизированных и открытых клинических исследований, посвященных анализу эффективности и безопасности назначения ацетилсалициловой кислоты и клопидогреля в периоперационном периоде. Представлены собственные данные о взаимосвязи между терапией ацетилсалициловой кислотой (Аспирин Кардио) в послеоперационном периоде и вероятностью рецидивирования клиники ИБС после хирургической реваскуляризации.
Об авторах
А. В. Панов
ФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия
Россия
М. Л. Гордеев
ФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия
Россия
В. Ю. Козулин
ФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия
Россия
К. В. Корженевская
ФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия
Россия
Н. А. Тян
ФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия
Россия
Список литературы
1. Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention // Circulation. - 1998. - Vol. 97. - P. 916 -931.
2.
3. Nezic D.G., Knezevic A.M., Milojevic P.S. et al. The fate of the radial artery conduit in coronary artery bypass grafting surgery // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 30. - P. 341-346.
4.
5. Cannon C.P., Mehta S.R., Aranki S.F. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery // Ann. Thorac. Surg. - 2005. - Vol. 80. - P. 768-779.
6.
7. Dacey L.J., Munoz J.J., Johnson E.R. et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients // Ann. Thorac. Surg. - 2000. - Vol. 70. -P. 1986-1990.
8.
9. Klein M., Keith P.R., Dauben H.P. et al. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with aspirin // Eur. J. Cardiothorac. Surg. - 1998. - Vol. 14. - P. 360-366.
10.
11. Bybee K.A., Powell B.D., Valeti U. et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting // Circulation. - 2005. - Vol. 112. - P. I286-I292.
12.
13. Mangano D.T. Aspirin and mortality from coronary bypass surgery // N. Engl. J. Med. - 2002. - Vol. 347. - P. 1309-1317.
14.
15. Michelson E.L., Morganroth J., Torosian M. et al. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery // J. Thorac. Cardiovasc. Surg. - 1978. - Vol. 76. - P. 694- 697.
16.
17. Taggart D.P., Siddiqui A., Wheatley D.J. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements // Ann. Thorac. Surg. - 1990. - Vol. 50. - P. 424-428.
18.
19. Ferraris V.A., Ferraris S.P., Joseph O. et al. Aspirin and postoperative bleeding after coronary artery bypass grafting // Ann. Surg. - 2002. - Vol. 235. - P. 820-827.
20.
21. Bashein G., Nessly M.L., Rice A.L. et al. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery // Arch. Intern. Med. - 1991. - Vol. 151. - P. 89-93.
22.
23. Srinivasan A.K., Grayson A.D., Pullan D.M. et al. Effect of preoperative aspirin use in off-pump coronary artery bypass operations // Ann. Thorac. Surg. - 2003. - Vol. 76. - P. 41-45.
24.
25. Alghamdi A.A., Moussa F., Fremes S.E. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis // J. Card. Surg. - 2007. - Vol. 22. - P. 247-256.
26.
27. Sun J.C., Whitlock R., Cheng J. et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies // Eur. Heart J. - 2008. - Vol. 29. - P. 1057-1071.
28.
29. Ferraris V.A., Ferraris S.P., Moliterno D.J. et al. The society of thoracic surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary) // Ann. Thorac. Surg. - 2005. - Vol. 79. - P. 1454-1461.
30.
31. Goldman S., Copeland J., Moritz T. et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study // Circulation. - 1989. - Vol. 80. - P. 1190-1197.
32.
33. Chesebro J.H., Fuster V., Elveback L.R. et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations // N. Engl. J. Med. - 1984. - Vol. 310. - P. 209-214.
34.
35. Goldman S., Copeland J., Moritz T. et al. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA cooperative study // Circulation. - 1994. - Vol. 89. - P. 1138-1143.
36.
37. Brooks N., Wright J., Sturridge M. et al. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion // Br. Heart J. - 1985. - Vol. 53. - P. 201-207.
38.
39. Gavaghan T.P., Gebski V., Baron D.W. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study // Circulation. - 1991. - Vol. 83. - P. 1526-1533.
40.
41. McEnany M.T., Salzman E.W., Mundth E.D. et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts // J. Thorac. Cardiovasc. Surg. - 1982. - Vol. 83. - P. 81-89.
42.
43. Sharma G.V., Khuri S.F., Josa M. et al. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency // Circulation. - 1983. - Vol. 68. - P. II218 -II221.
44.
45. Brown B.G., Cukingnan R.A., DeRouen T. et al. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery // Circulation. - 1985. - Vol. 72. - P. 138-146.
46.
47. Lim E., Ali Z., Ali A. et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery // Br. Med. J. - 2003. - Vol. 327. - P. 1309-1311.
48.
49. Fremes S.E., Levinton C., Naylor C.D. et al. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis // Eur. J. Cardiothorac. Surg. - 1993. - Vol. 7. - P. 169-180.
50.
51. Stein P.D., Schunemann H.J., Dalen J.E. et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy // Chest. - 2004. - Vol. 126 (3 Suppl.). - P. 600S-608S.
52.
53. Braunwald E., Antman E.M., Beasley J.W. et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) // Circulation. - 2002. - Vol. 106. -P. 1893-1900.
54.
55. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee // Lancet. - 1996. - Vol. 348. - P. 1329-1339.
56.
57. Yusuf S., Zhao F., Mehta S.R. et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation // N. Engl. J. Med. - 2001. - Vol. 345. - P. 494-502.
58.
59. Steinhubl S.R., Berger P.B., Mann J.T. III et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial // JAMA. - 2002. - Vol. 288. - P. 2411-2420.
60.
61. Saw J., Topol E.J., Steinhubl S.R. et al. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention // Am. J. Cardiol. - 2004. - Vol. 94. - P. 623-625.
62.
63. Gurbuz A.T., Zia A.A., Vuran A.C. et al. Postoperative Clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 29, № 2. - P. 190-195.
64.
65. Kulik A., Chan V., Ruel M. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy // Expert Opin. Drug Saf. - 2009. - Vol. 8, № 2. - P. 169-182.
66.
67. Kulik A., Le May M., Wells G.A. et al. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423] // Curr. Control Trials Cardiovasc. Med. - 2005. - Vol. 6. - P. 15.
68.
69. Clopidogrel and Aspirin after Surgery for Coronary Artery Disease Study (NCT00776477). ClinicalTrials.gov Web site. URL: http://www.clinicaltrials.gov/ct2/show/NCT007764
70.
71. Dunning J., Versteegh M., Fabbri A. et al. on behalf of the EACTS Audit and Guidelines Committee Guideline on antiplatelet and anticoagulation management in cardiac surgery // Eur. J. Cardiothorac. Surg. - 2008. - Vol. 34. - P. 73-92.
72.
Рецензия
Для цитирования:
Панов А.В., Гордеев М.Л., Козулин В.Ю., Корженевская К.В., Тян Н.А. Антиагрегантная терапия у больных ишемической болезнью сердца после хирургической реваскуляризации миокарда. Артериальная гипертензия. 2009;15(3):256-261. https://doi.org/10.18705/1607-419X-2009-15-3-256-261
For citation:
Panov A., Gordeev M.L., Kozulin V.Y., Korzhenevskaya K.V., Tyan N.A. Antiplatelet therapy in coronary artery disease after surgical revascularization. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2009;15(3):256-261. (In Russ.) https://doi.org/10.18705/1607-419X-2009-15-3-256-261
Просмотров:
959
Послать статью по эл. почте 